CompletedEUCTR 2015-003284-11
Safety study of Lu AF35700 in schizophrenia
This study is completed in Spain, in Czechia, in Slovakia, .... It is testing Lu AF35700 for schizophrenia.
In SpainSchizophreniaOther
Study directory
Back to overviewMental health studies with practical context.
Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
CompletedEUCTR 2014-003547-35
Brexpiprazole for depression
This study is completed in Estonia, in Germany, in Finland, .... It is testing brexpiprazole for depression.
In EstoniaDepressionOther
TerminatedEUCTR 2012-004169-42
Brexpiprazole for depression
This study was terminated in the United Kingdom, in Sweden, in Lithuania, .... It is testing brexpiprazole for depression.
In SwedenDepressionOther
CompletedEUCTR 2014-003569-12
Lu AF35700 for schizophrenia
This study is completed in Spain, in Estonia, in Finland, .... It is testing Lu AF35700 for schizophrenia.
In SpainSchizophreniaOther
CompletedEUCTR 2015-005081-30
Initial administration of 17 mg vortioxetine intravenously with 10 mg/day vortioxetine orally for Depression
This study is completed in Estonia, in Lithuania, in Finland, .... It is testing initial administration of 17 mg vortioxetine intravenously with 10 mg/day vortioxetine orally for Depression.
In EstoniaDepressionOther
CompletedEUCTR 2012-002252-17
Interventional, active-reference, flexible-dose study of brexpiprazole in people with acute schizophrenia
This study is completed in Czechia, in Germany, in Estonia, .... It is testing brexpiprazole for schizophrenia.
In Czech RepublicSchizophreniaOther
TerminatedEUCTR 2012-001361-32
Brexpiprazole (1 and 3 mg/day) for Depression
This study was terminated in the United Kingdom, in Sweden, in Lithuania, .... It is testing brexpiprazole (1 and 3 mg/day) for Depression.
In SwedenDepressionOther
CompletedEUCTR 2012-001380-76
Interventional, flexible-dose long-term study maintenance of efficacy and safety of 1 to 3 mg/day of brexpiprazole a...
This study is completed in the United Kingdom, in Estonia, in Sweden, .... It focuses on Depression.
In EstoniaDepressionOther
TerminatedEUCTR 2012-004982-41
Brexpiprazole for PTSD
This study was terminated in Estonia, in Italy, in Finland, .... It is testing brexpiprazole for PTSD.
In EstoniaPTSDOther
CompletedEUCTR 2008-005354-20
Vortioxetine for depression
This study is completed in France, in the United Kingdom, in Belgium, .... It is testing vortioxetine for depression.
In LatviaDepressionOther
CompletedEUCTR 2008-005353-38
Vortioxetine for depression
This study is completed in France, in the United Kingdom, in Latvia, .... It is testing vortioxetine for depression.
In LatviaDepressionOther
CompletedEUCTR 2017-000788-34
Efficacy of Lu AF35700 for schizophrenia
This study is completed in the United Kingdom and in Bulgaria. It is testing efficacy of Lu AF35700 for schizophrenia.
In BulgariaSchizophreniaOther
Public registry coverage is progressing
HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.